[1] Jensen TS , Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014; 13(9):924-935.
[2] Arendt-Nielsen L , Morlion B, Perrot S, et al. Assessment and manifestation of central sensitisation across different chronic pain conditions. Eur J Pain. 2018;22:216-241.
[3] Dahan A, van Velzen M, Niesters M. Comorbidities and the complexities of chronic pain. Anesthesiology. 2014;121:1-3.
[4] Coyle DE. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynicbehavior. Glia. 1998;23(1): 75-83.
[5] De Jong EK, Dijkstra IM, Hensens M, et al. Vesicle-mediated transport and release of CCL21 in endangered neurons:a possible explanation for microglia activation remote from a primary lesion. J Neurosci. 2005;25(33): 7548-7557.
[6] Belsky J, Pluess M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol Bull. 2009;135(6): 885-908.
[7] Verge GM, Milligan ED, Maier SF, et al. Fractakine (CX3CL1) and fractakine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci. 2004;20(5): 1150-1160.
[8] Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: A role for fractalkine. J Neuroimmunol. 2008;198(1/2): 113-120.
[9] Peoples LL. Neuroscience: will, anterior cingulate cortex, and addiction. Science. 2002;296(5573): 1623-1624.
[10] Wei F, Guo W, Zou SP, et al. Supraspinal Glial-Neuronal interactions contribute to descending pain facilitation. J Neurosci. 2008;28(42): 10482-10495.
[11] Milligan ED, Twining C, Chacur M, et al. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci. 2003;23(3): 1026-1040.
[12] Wieseler-Frank J, Maier SF, Watkins LR. Central proinflammatory cytokines and pain enhancement. Neurosignals. 2005;14(4): 166-174.
[13] Rappert A, Biber K, Nolte C, et al. Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J Immunol. 2002;168(7):3221.
[14] Soto H, Wang W, Strieter RM, et al. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci U S A. 1998;95(14): 8205-8210.
[15] Love M , Sandberg JL , Ziarek JJ , et al. Solution Structure of CCL21 and Identification of a Putative CCR7 Binding Site. Biochemistry. 2012; 51(3):733-735.
[16] Tsuda M, Masuda T, Tozaki-Saitoh H, et al. P2X4 receptors and neuropathic pain. Front Cell Neurosci. 2013;7:191
[17] Jiang Y, Bai J, Tang L, et al. Anti-CCL21 antibody attenuates infarct size and improves cardiac remodeling after myocardial infarction. Cell Physiol Biochem. 2015;37(3):979-990.
[18] Biber K, Boddeke E. Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic pain. Front Cell Neurosci. 2014;8:210.
[19] Xuan W, Qu Q, Zheng B, et al. The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 2014; 97(1):61-69.
[20] Biber K , Tsuda M , Tozaki-Saitoh H , et al. Neuronal CCL21 up-regulates microglia P2X4 expression and initiates neuropathic pain development. Embo J. 2011;30(9):1864-1873.
[21] Honjoh K, Nakajima H, Hirai T,et al. Relationship of Inflammatory Cytokines From M1-Type Microglia/Macrophages at the Injured Site and Lumbar Enlargement With Neuropathic Pain After Spinal Cord Injury in the CCL21 Knockout ( plt ) Mouse. Fronti Cell Neurosci. 2019; 21(9):525-526.
[22] Detloff MR, Fisher LC, Mcgaughy V, et al. Remote activation of microglia and pro-inflammatory cytokines predict the onset and severity of below-level neuropathic pain after spinal cord injury in rats. Exp Neurol. 2008; 212(2):337-347.
[23] Zhou X , He X , Ren Y. Function of microglia and macrophages in secondary damage after spinal cord injury. Neural Regen Res. 2014; 9(20):1787-1795.
[24] Liu J, Feng X , Yu M , et al. Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain. Neurosci Lett. 2007; 412(3):268-272. |